Sutro Biopharma, Inc. Soared

Thu, Apr 24, 2025 at 07:55 PM
Sutro Biopharma, Inc. Soared

Sutro Biopharma, Inc. (STRO:NASDAQ) shot up at $1.3, representing a gain of 44.4%. On Thu, Apr 24, 2025, STRO:NASDAQ hit a New 2-Week High of $1.3. The stock got featured on our News Catalysts scanner on Fri, Apr 18, 2025 at 03:13 AM in the 'BIOTECH' category. From Thu, Apr 10, 2025, the stock recorded 55.56% Up Days and 50.00% Green Days

About Sutro Biopharma, Inc. (STRO:NASDAQ)

Sutro Biopharma Inc is a clinical stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.